State of Alaska Department of Revenue Has $3.16 Million Position in Molina Healthcare, Inc $MOH

State of Alaska Department of Revenue increased its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 26.7% in the third quarter, Holdings Channel.com reports. The firm owned 16,500 shares of the company’s stock after buying an additional 3,475 shares during the quarter. State of Alaska Department of Revenue’s holdings in Molina Healthcare were worth $3,156,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in MOH. First Horizon Advisors Inc. lifted its stake in shares of Molina Healthcare by 2,140.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 112 shares of the company’s stock valued at $33,000 after acquiring an additional 107 shares during the last quarter. CYBER HORNET ETFs LLC bought a new position in Molina Healthcare in the second quarter valued at about $45,000. SJS Investment Consulting Inc. raised its position in Molina Healthcare by 6,225.0% in the third quarter. SJS Investment Consulting Inc. now owns 253 shares of the company’s stock valued at $48,000 after purchasing an additional 249 shares during the last quarter. MUFG Securities EMEA plc acquired a new stake in shares of Molina Healthcare during the second quarter valued at about $48,000. Finally, Zions Bancorporation National Association UT grew its holdings in shares of Molina Healthcare by 121.8% during the second quarter. Zions Bancorporation National Association UT now owns 193 shares of the company’s stock worth $57,000 after purchasing an additional 106 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Buying and Selling

In other news, Director Richard M. Schapiro sold 357 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $143.02, for a total transaction of $51,058.14. Following the completion of the transaction, the director directly owned 11,352 shares of the company’s stock, valued at $1,623,563.04. This represents a 3.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.26% of the company’s stock.

Molina Healthcare Stock Up 0.1%

MOH stock opened at $181.63 on Tuesday. The firm has a market capitalization of $9.84 billion, a PE ratio of 11.25 and a beta of 0.49. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.92. Molina Healthcare, Inc has a twelve month low of $133.40 and a twelve month high of $359.97. The stock’s 50 day moving average is $157.47 and its 200-day moving average is $176.56.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 EPS for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). The company had revenue of $11.48 billion during the quarter, compared to analysts’ expectations of $10.99 billion. Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $6.01 earnings per share. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. Sell-side analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on MOH. Jefferies Financial Group set a $160.00 price objective on shares of Molina Healthcare in a report on Tuesday, December 16th. Mizuho set a $220.00 price target on Molina Healthcare in a research note on Friday. Morgan Stanley set a $158.00 price target on shares of Molina Healthcare in a research report on Friday, October 24th. Wall Street Zen cut shares of Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Saturday, October 25th. Finally, UBS Group lowered their price objective on Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating for the company in a research report on Friday, October 24th. Three equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Molina Healthcare has a consensus rating of “Hold” and an average target price of $193.47.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.